Everything You Wanted to Know about COVID-19, and Maybe a Few - - PowerPoint PPT Presentation

everything you wanted to know
SMART_READER_LITE
LIVE PREVIEW

Everything You Wanted to Know about COVID-19, and Maybe a Few - - PowerPoint PPT Presentation

Partnering with Local Governments to Recruit, Assess and Develop Innovative, Collaborative, Authentic Leaders Everything You Wanted to Know about COVID-19, and Maybe a Few Things you Didnt. Safety and Survival in a V.U.U.C.C.A.


slide-1
SLIDE 1

Everything You Wanted to Know about COVID-19, and Maybe a Few Things you Didn’t….

Partnering with Local Governments to Recruit, Assess and Develop Innovative, Collaborative, Authentic Leaders

BILL PETERSON

  • Sr. Vice President, SGR

Former Regional DHS/FEMA Director

Safety and Survival in a V.U.U.C.C.A. Environment

slide-2
SLIDE 2

The Problem

We are peering into a void, of the great unknown, and trying to make sense of an array of data that doesn’t fit any morbidity and mortality model, because we have never been here before, and we don’t know how to model for public health conditions that have never existed before, in anyone’s lifetime. And, it's a VUUCCA incident, with widely variable geographic peculiarities.

slide-3
SLIDE 3

Safety and Survival in a VUCCA Environment

  • Volatile
  • Uncertain
  • Unprecedented
  • Complex
  • Chaotic
  • Ambiguous
slide-4
SLIDE 4

Seasonal Influenza – A Good baseline for Comparison

  • Seasonal flu sickens 15 million to 60 million Americans

each year,

  • About 200,000 are hospitalized with complications,
  • On average, 36,000 Americans die each year of seasonal

influenza,

  • In Florida, that’s like losing a little less than the entire

population of Clermont every year,

slide-5
SLIDE 5

Just how contagious is COVID 19?

slide-6
SLIDE 6

6

WWW.GOVERNMENTRESOURCE.COM

slide-7
SLIDE 7

7

WWW.GOVERNMENTRESOURCE.COM

slide-8
SLIDE 8

8

WWW.GOVERNMENTRESOURCE.COM

slide-9
SLIDE 9

9

WWW.GOVERNMENTRESOURCE.COM

slide-10
SLIDE 10

Novel Influenza Viruses of the 20th and 21st Centuries Global Impacts of the 20th and 21st Century Flu Pandemics

10

1918 Spanish Flu (H1N1) 1957 Asian Flu (H2N2) 1968 Hong Kong Flu (H3N2) Step.4

WWW.GOVERNMENTRESOURCE.COM

  • Virus of avian origin
  • Began in the US
  • 1/3 of world’s population infected
  • 675,000 deaths in the US
  • 50 million deaths globally
  • Virus of avian origin
  • Began in Singapore

1968 Hong Kong Flu (H3N2)

  • 116,000 deaths in the US
  • 1.1 million deaths globally
  • Virus of avian origin
  • Began in the US
  • 100,000 deaths in the US
  • Estimated 1 million deaths globally

2009 H1N1 Pandemic

  • Virus of swine origin
  • Began in Mexico
  • 12,000 deaths in the US
  • Estimated 150,000 – 575,000

deaths globally

slide-11
SLIDE 11

Influenza Viruses Studied as Potential Pandemic Threats

Avian Influenza Viruses Being Tracked for Pandemic Potential H5N1 H5N6 H6N1 H7N9 H10N8

slide-12
SLIDE 12

Novel Coronaviruses

What is a coronavirus?

Named after the appearance of a “corona”

  • r crown, when viewed by

electron microscopy.

SARS coronavirus Image courtesy of New Scientist

slide-13
SLIDE 13

Coronaviruses are Common Pathogens in Several Species of Mammals

Host Species for Coronavirus

  • Bats
  • Camels
  • Cattle
  • Cats
  • Pangolins
slide-14
SLIDE 14

7 Known Types of Coronavirus Capable of Causing Human Illness

  • MERS-CoV – a betacoronavirus that

causes Middle Eastern Respiratory Syndrome

  • SARS-CoV-1 – a betacoronavirus that

causes Severe Acute Respiratory Syndrome

  • 2019-nCoV (COVID-19) (SARS-CoV-2) – a

betacoronavirus that causes COVID-19 disease Cause Mild to Moderate Illness Similar to the “Common Cold” Cause Severe Disease in People

  • 229E – an alphacoronavirus
  • NL63 – an alphacoronavirus
  • OC43 – a betacoronavirus
  • HKU1 – a betacoronavirus
slide-15
SLIDE 15

Origin of COVID-19 Coronavirus-

➢Allegations of origin in Wuhan, China “Live Market.” ➢Wuhan is also the location for the Wuhan Institute of Virology ➢Coincidence or Complicity? Who was Patient “0”?

slide-16
SLIDE 16

16

WWW.GOVERNMENTRESOURCE.COM

How Does COVID-19 (SARS-CoV-2) Infect People?

Human to Human Transmission

  • Direct contact - assumed
  • Indirect contact (fomites & physical environment)

– unknown but assumed

  • Droplets (large aerosols from coughing,

sneezing, speaking) – assumed, with growing evidence of certainty

  • Airborne (after water from aerosols evaporates,

viruses remain suspended in air) – Highest potential danger (e.g. measles virus) – assumed

  • Fecal-oral route – (touching people or

materials/objects with microscopic particles of infected feces/consuming food or drink contaminated with infected feces) – unknown, but COVID-19 virus found in patients’ feces and water samples from early December 2019

slide-17
SLIDE 17

What Makes the COVID-2019 Coronavirus Outbreak So Different?

1. Compared to SARS and MERS, this betacoronavirus is spreading more rapidly, and appears more like a novel flu pandemic 2. The power of social media, available to the general population in China and elsewhere, has literally changed the game in terms of information spread (information that is both true and false) – the “Infodemic” 3. China and other nations have made rapid decisions to enforce community mitigation techniques (non- pharmaceutical interventions) and are using them to an unprecedented scale – CDC says US states, counties, and cities should also be useing these NPI’s (they have already!) 4. As with SARS and MERS, there are no current pharmaceutical interventions for this coronavirus illness (no vaccine and no proven effective drug treatments)

SGR Phrases: “Corona-anxiety” or Coronaphobia”

slide-18
SLIDE 18

Major Concerns

1.The Health Care System has no Surge capacity, (J.I.T. Economy) 2.Here in the US, initial testing for the Coronavirus was limited, 3.The people at greatest risk for Coronavirus related mortality are already

  • ur most vulnerable age group, (40% Nursing Home fatalities).

4.Hoarding of masks and other protective equipment has stressed the supply chain, putting our health care workers, and others, at risk,

  • 5. Political pressure has made it difficult for Health Officials to tell the truth,
  • 6. Approximately 35% of those who get COVID are asymptomatic,
  • 7. A significant segment of our population thinks this is “Fake News” (Impact of

Social Media to spread Conspiracy Theories).

18

WWW.GOVERNMENTRESOURCE.COM

slide-19
SLIDE 19

Important Reasons for Optimism:

1. We know the disease is mild for most people who do get it,

  • 2. Children

seem to be protected from severe Coronavirus disease,

  • 3. There has been, and continues to be, extraordinary global

cooperation from doctors, scientists, and health officials,

  • 4. Early on, there was exceptional acceptance of the social

distancing concept and practices,

  • 5. Historic progress is being made on the development of a

vaccine.

19

WWW.GOVERNMENTRESOURCE.COM

slide-20
SLIDE 20

Unanswered Questions: As of May 8, 2020

  • 1. How did the new coronavirus get into people?
  • 2. How many people have actually gotten COVID-19?
  • 3. How, exactly, does Covid-19 spread?
  • 4. What makes the coronavirus so good at spreading?
  • 5. How many cases of Covid-19 are in the US, and where are we on the curve?
  • 6. What drives mortality in people infected by the coronavirus?
  • 7. What percent of people infected by the coronavirus die?
  • 8. Why do young people face the least risk of dying?
  • 9. What role do children play in being able to transmit the virus to others?

10.If you recover from the virus, how long will you have immunity? 11.Can you get re-infected? 12.How seasonal is the coronavirus?

20

WWW.GOVERNMENTRESOURCE.COM

slide-21
SLIDE 21

Unanswered Questions: As of May 8, 2020

  • 13. How long will we be using Social Distancing as a precaution against

infection?

  • 14. Are there any safe and effective drugs to treat COVID-19?
  • 15. Will there be a vaccine for the coronavirus, and when?
  • 16. What are the long-term consequences for those who survive COVID-19?
  • 17. Will there be a second wave of the virus?
  • 18. When will it end? And how?
  • 19. Will COVID-19 be with us forever (endemic)?
  • 20. Will our government and society accept additional deaths as an alternative

to sustaining the national economy?

21

WWW.GOVERNMENTRESOURCE.COM

slide-22
SLIDE 22

What’s Necessary for Successful Containment

▪ Florida needs to test a larger percentage of the state’s population, ▪

Isolate those who test positive,

▪ Track down their contacts and ▪ Order those people to quarantine themselves for two weeks. ▪ Massive, ongoing testing to detect where the disease is spreading, ▪ A real-time ability to trace contacts of those infected and isolate them, ▪ A willingness of people to wear masks in crowded public spaces, ▪ Reserves of personal protective equipment (PPE) and other equipment for hospital workers to handle any surge in cases, ▪ And reliable, easily administered blood tests to find out the number of people who have been infected.

22

WWW.GOVERNMENTRESOURCE.COM

slide-23
SLIDE 23

What’s Necessary for Successful Containment

According to a panel of public health experts convened by Harvard University, though, the country needed to be conducting Five (5) Million tests a day by early June for a safe social reopening, and ramping up to 20 million a day by late July. The experts said: ”Doing so, will require personnel and lab capacity for testing and contact tracing that is perhaps an order of magnitude greater than what is currently available.” And they say it will be expensive.

23

WWW.GOVERNMENTRESOURCE.COM

slide-24
SLIDE 24

The Current Harsh Reality-

“We have to all acknowledge that we will have to live with Corona for at least a year and probably two or three years,” said Dr. Ansgar Lohse, a professor at University Medical Center in Hamburg and co-author of a paper that sets out a “flexible, risk-adjusted strategy” for reopening commerce in Germany.

24

WWW.GOVERNMENTRESOURCE.COM

slide-25
SLIDE 25

The Struggle -

The Economic Impact vs. The Medical Impact (Bio ethics) ▪Testing numbers need to be increased – 7 to 20 million per day. The test processing capability is a big restriction (Lab capacity), ▪Contact tracers - we need an increase of 10-55 x the numbers we have available today. ▪Need - 150k - 300k nationally

25

WWW.GOVERNMENTRESOURCE.COM

slide-26
SLIDE 26

Vaccine Development Status - Only the First Step

How many doses do we need? 400 to 800 Million, in the first year

slide-27
SLIDE 27

The Future Struggle -

The looming vaccine distribution logistical challenge -

▪ Ramping up production of syringes and other medical products to deliver a coronavirus vaccine will be as important — and perhaps as difficult — as developing the vaccine itself. ▪ In the U.S., more than 300 million people may need to be inoculated, and products that doctors now give little thought to could easily become obstacles in the future. ▪ The glass vials the vaccine is stored in, or rubber stoppers in the vials, or the plungers in the syringes could become the constraining factor in the health care supply chains.

27

WWW.GOVERNMENTRESOURCE.COM

slide-28
SLIDE 28

TRACKING RESOURCES

https://experience.arcgis.com/experience/96dd742462124fa0b38ddedb9b25e429 Florida Department of Health COVID-19 Data and Surveillance Dashboard

slide-29
SLIDE 29

TRACKING RESOURCES

Johns Hopkins University Center for Systems Science and Engineering (CSSE) COVID-19 Dashboard https://experience.arcgis.com/experience/96dd742462124fa0b38ddedb9b25e429

slide-30
SLIDE 30

Questions?

slide-31
SLIDE 31

Thank You!

William (Bill) Peterson, Senior Vice President, M.A., CEM, CFIFireE Bill@governmentresource.com Mobile – 469.450.4442 Office – 407.201.8933

slide-32
SLIDE 32